|
⚲
|
| Keyboard |
| Linden Capital LP
✚
|
|
|---|---|
| CIK # | 0001349339 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001349339] | |
| 4 | [0001349339] | |
| SC 13D | [0001349339] | |
| SC 13G | [0001349339] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Linden Capital LP | |
| Tetralogic Pharmaceuticals Corp | |
| Linden Advisors LP |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Tetralogic Pharmaceuticals Corp TLOG
8% Senior Convertible Notes due 2024 · derivative
|
2016-11-14 | Other | |||
|
Tetralogic Pharmaceuticals Corp TLOG
Preferred Stock · derivative
|
2016-11-14 | Other | |||
|
Tetralogic Pharmaceuticals Corp TLOG
8% Senior Convertible Notes due 2019 · derivative
|
2016-11-14 | Other | 2,095,239 |